Philip Stegmaier

723 total citations
21 papers, 498 citations indexed

About

Philip Stegmaier is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Philip Stegmaier has authored 21 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Genetics. Recurrent topics in Philip Stegmaier's work include Bioinformatics and Genomic Networks (7 papers), Genomics and Chromatin Dynamics (7 papers) and Gene expression and cancer classification (5 papers). Philip Stegmaier is often cited by papers focused on Bioinformatics and Genomic Networks (7 papers), Genomics and Chromatin Dynamics (7 papers) and Gene expression and cancer classification (5 papers). Philip Stegmaier collaborates with scholars based in Germany, Russia and Taiwan. Philip Stegmaier's co-authors include Alexander Kel, Edgar Wingender, Olga Kel‐Margoulis, Nico Voss, Tim Beißbarth, Florian Auer, Frank Krämer, Annalen Bleckmann, Kerstin Menck and Júlia Perera‐Bel and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Philip Stegmaier

21 papers receiving 489 citations

Peers

Countries citing papers authored by Philip Stegmaier

Since Specialization

Citations

This map shows the geographic impact of Philip Stegmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Stegmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Stegmaier more than expected).

Fields of papers citing papers by Philip Stegmaier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Stegmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Stegmaier. The network helps show where Philip Stegmaier may publish in the future.

Co-authorship network of co-authors of Philip Stegmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Stegmaier. A scholar is included among the top collaborators of Philip Stegmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Stegmaier. Philip Stegmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Text mining-based word representations for biomedical data analysis and protein-protein interaction networks in machine learning tasks 2021 ·PLoS ONE ·(unknown), (unknown), Tim Beißbarth, Edgar Wingender, Philip Stegmaier	12
2	Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer 2021 ·Genome Medicine ·(unknown), Annalen Bleckmann, Kerstin Menck, Júlia Perera‐Bel, Philip Stegmaier, Florian Auer, Frank Krämer, Andreas Leha, Tim Beißbarth	70
3	Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease 2020 ·Disease Models & Mechanisms ·(unknown), Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, François Bergey, (unknown), (unknown), Hazel England, David G. Spiller, Michael White, Carrie A. Duckworth, Barry J. Campbell, Vladimir Poroikov, Vítor A. P. Martins dos Santos, Alexander Kel, Werner Müller, D. Mark Pritchard, Chris Probert, Michael D. Burkitt	11
4	Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response—What is First? 2020 ·International Journal of Molecular Sciences ·Alexander N. Orekhov, Vasily N. Sukhorukov, Nikita G. Nikiforov, (unknown), Igor A. Sobenin, (unknown), (unknown), Philip Stegmaier, (unknown), Alexander Kel, Anastasia V. Poznyak, Wei‐Kai Wu, Artem S. Kasianov, Vsevolod J. Makeev, Ichiro Manabe, Yumiko Oishi	32
5	Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis 2020 ·International Journal of Molecular Sciences ·Alexander N. Orekhov, Nikita G. Nikiforov, Vasily N. Sukhorukov, (unknown), Igor A. Sobenin, Wei‐Kai Wu, (unknown), (unknown), Philip Stegmaier, (unknown), Alexander Kel, Alexei Gratchev, Alexandra А. Melnichenko, Reinhard Wetzker, Volha I. Summerhill, Ichiro Manabe, Yumiko Oishi	24
6	Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer 2019 ·BMC Bioinformatics ·Alexander Kel, U. A. Boyarskikh, Philip Stegmaier, (unknown), Andrey V. Sokolov, Ivan Yevshin, (unknown), (unknown), (unknown), Olga Kel‐Margoulis, Mathias Krull, Anna Martínez‐Cardús, Sebastián Morán, Manel Esteller, Fedor Kolpakov, М. Л. Филипенко, Edgar Wingender	39
7	Computational master-regulator search reveals mTOR and PI3K pathways responsible for low sensitivity of NCI-H292 and A427 lung cancer cell lines to cytotoxic action of p53 activator Nutlin-3 2018 ·BMC Medical Genomics ·U. A. Boyarskikh, (unknown), (unknown), (unknown), Ilya Kiselev, (unknown), Ruslan Sharipov, Philip Stegmaier, Fedor Kolpakov, М. Л. Филипенко, Alexander Kel	12
8	OTU-001 Identification of a novel therapeutic agent for treating IBD guided by systems medicine 2018 ·Michael D. Burkitt, (unknown), Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, D. Mark Pritchard, Alexander Kel, Werner Müller, Chris Probert	1
9	geneXplainR: An R interface for the geneXplain platform 2017 ·The Journal of Open Source Software ·Philip Stegmaier, Alexander Kel, Edgar Wingender	3
10	Multi-omics “upstream analysis” of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer 2016 ·PubMed ·Alexander Kel, Philip Stegmaier, (unknown), (unknown), Vladimir Poroikov, Olga Kel‐Margoulis, Edgar Wingender	29
11	“Upstream Analysis”: An Integrated Promoter-Pathway Analysis Approach to Causal Interpretation of Microarray Data 2015 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Philip Stegmaier, Alexander Kel, Edgar Wingender	51
12	A Discriminative Approach for Unsupervised Clustering of DNA Sequence Motifs 2013 ·PLoS Computational Biology ·Philip Stegmaier, Alexander Kel, Edgar Wingender, Jürgen Borlak	7
13	3DTF: a web server for predicting transcription factor PWMs using 3D structure-based energy calculations 2012 ·Nucleic Acids Research ·Razif Gabdoulline, Denitsa Eckweiler, Alexander Kel, Philip Stegmaier	15
14	Advanced Computational Biology Methods Identify Molecular Switches for Malignancy in an EGF Mouse Model of Liver Cancer 2011 ·PLoS ONE ·Philip Stegmaier, Nico Voss, (unknown), Alexander Kel, Edgar Wingender, Juergen Borlak	18
15	Molecular mechanistic associations of human diseases 2010 ·BMC Systems Biology ·Philip Stegmaier, Mathias Krull, Nico Voss, Alexander Kel, Edgar Wingender	11
16	Creating PWMs of transcription factors using 3D structure-based computation of protein-DNA free binding energies 2010 ·BMC Bioinformatics ·(unknown), Philip Stegmaier, Alexander Kel	20
17	ExPlain™: finding upstream drug targets in disease gene regulatory networks 2008 ·SAR and QSAR in environmental research ·Alexander Kel, Nico Voss, (unknown), Philip Stegmaier, Olga Kel‐Margoulis, Edgar Wingender	30
18	ExPlain, finding upstream drug targets in disease gene regulatory networks. SAR QSAR Environ Res 19(5-6):481-494 2008 ·Alexander Kel, Neil Voss, (unknown), Philip Stegmaier, (unknown), Edgar Wingender	10
19	Composite Module Analyst: identification of transcription factor binding site combinations using genetic algorithm 2006 ·Nucleic Acids Research ·(unknown), Dmitry Shtokalo, Tatiana Konovalova, Nico Voss, (unknown), Philip Stegmaier, Olga Kel‐Margoulis, Edgar Wingender, Alexander Kel	45
20	Systematic DNA-binding domain classification of transcription factors. 2004 ·PubMed ·Philip Stegmaier, Alexander Kel, Edgar Wingender	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact